Skip to main content
SN

Scintillation Nanotechnologies

Scintillation Nanotechnologies develops proprietary nanomaterials that significantly enhance the sensitivity and accuracy of radioisotope detection in various applications. Their technology improves detection methods critical for nuclear safety, medical diagnostics, and environmental monitoring.

Vail, United StatesFounded 201841K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional methods for detecting radiolabeled compounds often involve organic solvents, generate significant waste, and lack the sensitivity for demanding biochemical assays, particularly in live-cell applications. Existing radioisotope detection products also face limitations in dispersibility and maintaining suspension in aqueous solutions.

Solution

Scintillation Nanotechnologies (SNT) develops and offers a range of nanomaterials designed to enhance the detection of radiolabeled compounds. Their core technology revolves around radioisotope-responsive nanoparticles that overcome the limitations of conventional methods. SNT's products, including the aquaSCINT™ and nanoSPA™ families, enable high-sensitivity, high-resolution measurements in various applications. The aquaSCINT™ products facilitate continuous, non-specific detection in aqueous environments without organic solvents, reducing waste and enhancing biocompatibility. The nanoSPA™ products are nanoparticle scintillators designed for scintillation proximity assays (SPA) in aqueous samples, offering improved dispersibility and suspension properties.

Target Audience

The primary target audience includes researchers and professionals in nuclear safety, medical diagnostics, and environmental monitoring who require enhanced sensitivity and accuracy in radioisotope detection.

Features

  • **aquaSCINT™:** Enables continuous, non-specific detection of radiolabeled compounds in aqueous environments.
  • **aquaSCINT™-IC:** Modified for easy incorporation into mammalian cells, allowing continuous, intracellular measurements without repeated sample preparations.
  • **nanoSPA™:** Designed for scintillation proximity assays (SPA) with improved dispersibility and suspension.
  • **nanoSPA™-LA:** Features an added coating to reduce non-specific adsorption in challenging SPA assays.
  • **Silica Surface:** Nanoparticles feature a silica surface for easy dispersion in water and surface functionalization.
  • **Small Size:** Nanoparticles average 300nm in diameter, suitable for incorporation into cells.
  • **Low Density:** Low density ensures materials stay in suspension longer than competing products.
  • Compatible with existing scintillation counters for detecting alpha and beta-emitting radioisotopes.
This profile is AI-generated and may contain inaccuracies.